Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

Overview of attention for article published in Frontiers in Pharmacology, November 2020

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells. https://t.co/PTs6zhChJJ #breastcancer #oncology https://t.co/t54x3TDpRp

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.